|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Operating expenses: | |||||
| Cost of sales | |||||
| Selling, general and administrative | |||||
| Amortization | |||||
| Restructuring | |||||
| Gain on autonomous driving joint venture, net | |||||
| Goodwill impairment | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Interest expense | |||||
| Other income (expense), net | |||||
| Income before income taxes and equity loss | |||||
| Income tax (expense) benefit | |||||
| Income before equity loss | |||||
| Equity loss, net of tax | |||||
| Net income | |||||
| Net income attributable to noncontrolling interest | |||||
| Net loss attributable to redeemable noncontrolling interest | |||||
| Net income attributable to Aptiv | |||||
| Mandatory convertible preferred share dividends | |||||
| Net income attributable to ordinary shareholders | |||||
| Basic net income per share: | |||||
| Basic net income per share attributable to ordinary shareholders | |||||
| Weighted average ordinary shares outstanding, basic | |||||
| Diluted net income per share: | |||||
| Diluted net income per share attributable to ordinary shareholders | |||||
| Weighted average number of diluted shares outstanding |
Loading...